Using an AI virtual assistant to help manage heart failure patients after hospital discharge
Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure: A Randomized Controlled Pilot Study: ASSIST-HF SIRIO
This study tests if using an AI virtual assistant can help heart failure patients manage their care at home better after leaving the hospital.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | East and North Hertfordshire NHS Trust Government |
| Locations | 1 site (Stevenage, Hertfordshire) |
| Trial ID | NCT06400927 on ClinicalTrials.gov |
What this trial studies
This pilot study investigates the integration of the SIRIO-HF virtual assistant into the outpatient management of patients recently diagnosed with heart failure. The aim is to determine if this AI-powered tool can reduce the need for regular medical assessments, lower healthcare burdens, and enhance patient satisfaction while maintaining safety and care quality. Participants will be randomized to receive either the virtual assistant alongside standard care or standard care alone. The study focuses on patients discharged from the hospital with New York Heart Association class II-III symptoms.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been newly diagnosed with heart failure and exhibit class II-III symptoms at discharge.
Not a fit: Patients with a prior history of heart failure, severe comorbidities, or cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could streamline outpatient management for heart failure patients, potentially improving their quality of life and reducing healthcare costs.
How similar studies have performed: While the use of AI in healthcare is a growing field, this specific approach to managing heart failure with a virtual assistant is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Newly diagnosed HF with New York Heart Association class II-III symptoms at discharge Exclusion Criteria * Known prior history of HF * Severe comorbidities that could affect protocol adherence, in the opinion of the investigator * Alternative diagnosis for symptoms such as chronic obstructive pulmonary disease * Dementia or other cognitive impairment * Currently involved in another interventional clinical trial
Where this trial is running
Stevenage, Hertfordshire
- East and North Hertfordshire NHS Trust — Stevenage, Hertfordshire, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Diana A Gorog, MD, PhD — East and North Hertfordshire NHS Trust
- Study coordinator: Joshua H Leader, MBChB, BSc
- Email: joshua.leader@nhs.net
- Phone: 07376188768
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.